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minor inflammatory response is observed when ticks are
feeding on their natural hosts. This absence of efficient
rejection is due to tick immunomodulating factors secreted
into the feeding lesion. A number of host physiological pro-
cesses, including haemostasis, vasoconstriction, inflam-
mation and pain perception, are targeted by the molecules
secreted in tick saliva (Ribeiro 
 
et al
 
., 1985; Limo 
 
et al
 
.,
1991). Several observations suggest that inhibition of
the host complement alternative pathway is crucial for
the achievement of tick blood feeding. First, it has been
demonstrated that the saliva of several 
 
Ixodes
 
 species con-
tains an inhibitor of the alternative pathway (Ribeiro, 1987;
Lawrie 
 
et al
 
., 2005). Second, the host range of 
 
Ixodes
 
 ticks
correlates with their ability to counteract the alternative
pathway of their most common host species (Lawrie 
 
et al
 
.,
1999). Third, cases of host resistance to ticks have been
described in which the complement system is implicated
with a predominant part of the alternative pathway (Wikel,
1979; Ribeiro, 1987; Lawrie 
 
et al
 
., 1999).
A recent study has described the cloning of a novel salivary
anticomplement protein from the American tick 
 
I. scapularis
 
(Valenzuela 
 
et al
 
., 2000). This a 18.5 kDa protein, termed
 
I. scapularis
 
 anticomplement protein or Isac, behaves as a
regulator of the alternative pathway in a manner similar to
two cellular RCA proteins, decay accelerating factor (DAF)
and factor H (Valenzuela 
 
et al
 
., 2000). Surprisingly, Isac
has no similarity to any previously described anticomple-
ment molecules. However, the presence of four cysteines
in Isac suggests that it could be a functional homologue of
SCR derived by convergent evolution. Subsequently, sev-
eral sequences homologous to Isac were described among
cDNAs isolated from 
 
I. scapularis
 
 salivary glands (Das
 
et al
 
., 2001; Soares 
 
et al
 
., 2005; Ribeiro 
 
et al
 
., 2006), and
one cDNA homologue of Isac, called ISAC-1, has been
reported from 
 
I. pacificus
 
 (Francischetti 
 
et al
 
., 2005). The
activity of these expression products is still unknown.
 
I. scapularis
 
 and 
 
I. pacificus
 
 belong to the 
 
Ixodes ricinus
 
species complex, a group of closely related hard ticks com-
prising at least 14 species distributed throughout the world
(Keirans 
 
et al
 
., 1999; Xu 
 
et al
 
., 2003). The initial goal of
the present study was to clone the orthologue of Isac from
the European tick 
 
I. ricinus
 
. Surprisingly, two different
sequences homologous to Isac were isolated from the
transcriptome of 
 
I. ricinus
 
 salivary glands. Expression of
these cDNAs revealed that they both encode functional
homologues of Isac, and so we have named these proteins
 
I. ricinus
 
 anticomplement (IRAC) protein I and II. 
 
In vivo
 
analyses revealed that IRAC I and IRAC II are encoded by
distinct genes rather than alleles of the same locus, and
that both IRAC I and IRAC II are coexpressed constitutively
in 
 
I. ricinus
 
 salivary glands but are upregulated during blood
feeding. Phylogenetic analyses of the 
 
I. scapularis
 
, 
 
I. pacifi-
cus
 
 and 
 
I. ricinus
 
 Isac homologues revealed that ticks
belonging to the 
 
I. ricinus
 
 complex encode a family of
relatively small anticomplement molecules that have diver-
sified through a process of positive Darwinian selection.
The potential of this family of proteins as antigens for the
development of an antitick vaccine able to induce an early
rejection of the tick and/or inhibition of transmission of
tick-borne diseases will be discussed.
 
Results
 
Identification of Isac homologues in 
 
Ixodes ricinus
 
 ticks
 
With the aim of cloning the orthologue of 
 
I. scapularis
 
 Isac
from the European tick 
 
I. ricinus
 
, a reverse transcriptase–
polymerase chain reaction (RT–PCR) approach was per-
formed on mRNA purified from salivary glands of engorged
adult female ticks. Surprisingly, use of a unique sense
primer based on the sequence upstream of the 
 
I. scapularis
 
Isac open reading frame (Valenzuela 
 
et al
 
., 2000) and a
poly dT reverse primer, resulted in the amplification of two
distinct sequences homologous to Isac. The potential open
reading frames within these sequences were called IRAC I
and II. Comparison of IRAC I and Isac revealed that they
encode 184 amino acids proteins with only 65.8% identity
(Fig. 1 and Table 1). The expression product of IRAC II is
six amino acids shorter, due to two small deletions not
Table 1.
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affecting the reading frame, and exhibits 66.3% and 68.0%
amino acid identity with the IRAC I and Isac proteins,
respectively (Table 1). Analysis of IRAC I and II sequences
suggested that both proteins have a putative N-terminal
signal peptide characteristic of secreted proteins (SignalP,
CBS, http://www.cbs.dtu.dk/services/SignalP). The putative
secreted forms of IRAC I and IRAC II have predicted mole-
cular masses of 20.3 and 19.6 kDa, respectively (Compute
pI/Mw Tool, ExPASy, http://uw.expasy.org/tools/pi_tool.html).
Importantly, both IRAC proteins possess the four cysteines
described in Isac and suspected to be important for its
anticomplement activity (Fig. 1). Together these results
suggest that IRAC proteins could be functional homo-
logues of Isac secreted in the saliva of 
 
I. ricinus
 
 ticks.
 
Anticomplement properties of IRAC proteins
 
To test the ability of the IRAC I and II expression products
to inhibit complement, these proteins were expressed in
HeLa cells. Concentrated cell supernatants were prepared
from cultures transfected with the empty vector or derived
vectors encoding IRAC I or IRAC II. Western blot analysis of
concentrated cell supernatants revealed that they contained
Figure 1. Alignment of Ixodes ricinus IRAC I and IRAC II proteins and homologous proteins described from I. scapularis and I. pacificus. Amino acid residues 
are numbered with respect to the translation initiation methionine. Residues identical across all sequences are indicated by boxes; those shared by some of the 
sequences are highlighted in grey. The four cysteines suspected to be important for Isac anticomplement properties are indicated by asterisks.
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similar amounts of IRAC I or IRAC II proteins. Analysis of these
supernatants did not reveal any inhibitory effect of IRAC I or
IRAC II on the classical pathway (data not shown). However,
a dose-dependent inhibition of the alternative pathway was
observed for both IRAC I and IRAC II (Fig. 2A) as measured
by their ability to inhibit the lysis of rabbit erythrocytes by
human serum. Statistical analysis of IRAC I and IRAC II dose–
effect curves revealed that they are significantly different
(
 
P
 
 < 0.05) and suggests that IRAC II is more effective than
IRAC I under the conditions of this assay. Taken together,
these results demonstrate that IRAC I and IRAC II are
secreted inhibitors of the complement alternative pathway.
Figure 2. (A) Inhibition of the alternative 
pathway by IRAC I and IRAC II proteins. HeLa 
cells were transfected with pcDNA4/TO-IRAC-I, 
pcDNA4/TO-IRAC-II or pcDNA4/TO vectors and 
then treated as described in the experimental 
procedures for production of concentrated cell 
supernatants. The ability of concentrated cell 
supernatants to inhibit the complement 
alternative pathway was assayed by addition of 
the indicated volume. The data presented are the 
mean ± SD for triplicate measurements, 
expressed as the percentage of lysis observed 
with concentrated cell supernatant from 
pcDNA4/TO transfected cultures. Bottom of 
panel A. Immunoblot analysis of concentrated 
cell supernatants. (B) Effect of IRAC I and 
IRAC II proteins on C3b and fB deposition to 
agarose-coated plates. The ability of IRAC I and 
IRAC II to inhibit the binding of C3b (panel a) or 
fB (panel c), or to induce the decoupling of 
prebound C3b (panel b) or fB (panel d) was 
investigated as described in the procedures. 
Controls, IRAC I and IRAC II were run 
with concentrated supernatant from cell 
cultures transfected with pcDNA4/TO, pcDNA4/
TO-IRAC-I and pcDNA4/TO-IRAC-II vectors, 
respectively. The data presented are the average 
± SD for triplicate measurements, expressed as 
percentages of the optical density observed for 
controls.
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To further characterize the anticomplement activity of
IRAC molecules, concentrated cell supernatants were
submitted to C3b and fB ELISA tests as described previ-
ously by Valenzuela 
 
et al
 
. (2000) (Fig. 2B). These assays
revealed that IRAC I and IRAC II inhibited the binding of
C3b to agarose-coated wells, but did not uncouple co-
valently prebound C3b (Fig. 2B, panels a and b). Factor B
attaches noncovalently to C3b. Both IRAC molecules
inhibited the binding of fB to C3b and induced the displace-
ment of prebound fB (Fig. 2B, panels c and d).
 
Immunodetection of IRAC proteins in tick salivary glands
 
With the goal in mind to detect IRAC molecules 
 
in situ
 
,
mouse polysera were raised against IRAC molecules
expressed as His-tagged proteins. Immunostaining of
HeLa cells expressing IRAC I or IRAC II with the polysera
obtained revealed a strong staining of expressing cells but
also a cross-reaction of the polysera for the two proteins
(Fig. 3, compare panels c and d or panels e and f). To avoid
the latter problem resulting from the homology existing
between IRAC molecules, monoclonal antibodies (mAbs)
specific of IRAC I or IRAC II were produced. Their specificity
is demonstrated in Fig. 3B. These mAbs were then used
to stain cryosections performed through unfed or 4-day
engorged ticks. These stainings revealed that both proteins
are expressed constitutively in 
 
I. ricinus
 
 salivary glands and
are upregulated during blood feeding (Fig. 4). Stainings
performed with an isotypic control mAb demonstrated the
specificity of the signals observed.
 
Identification of IRAC I and II as the expression products of 
different genes
 
The extent of divergence between the IRAC I and IRAC II
sequences (Fig. 1 and Table 1) is much greater than would
be expected for alleles from one locus, strongly suggesting
that these proteins result from the expression of two
different genes. To test this hypothesis, 12 ticks collected
from different locations in Belgium were microdissected: for
each tick, left and right salivary glands were isolated and
stained with mAbs specific to IRAC I and IRAC II, respec-
tively (Fig. 5). All 12 ticks were found to express both IRAC I
and IRAC II. Even at the maximum possible expected
heterozygosity (i.e. 0.5 for two alleles, when they have
equal frequencies), the chance of finding 12 heterozygote
ticks (i.e. ticks expressing both IRAC I and IRAC II) among
a sample of 12 is extremely small (
 
P
 
 = 0.5
 
12
 
 = 0.00024).
Thus, these expression data lend strong support to the
hypothesis that IRAC I and IRAC II are encoded by sepa-
rate genes.
 
Evolutionary relationships of the IRAC genes
 
A number of sequences homologous to Isac, IRAC I and
IRAC II have been reported. One, ISAC-1, was isolated
from 
 
I. pacificus
 
 salivary glands (Francischetti 
 
et al
 
., 2005).
The others were isolated from 
 
I. scapularis
 
 salivary glands:
Salp9 and Salp20 (Das 
 
et al
 
., 2001), clones 113, 120 and
122 (Soares 
 
et al
 
., 2005), and isolates ISNU-L-ISN-50,
ISNU-L-ISNU-51, ISNU-cluster-52 and IS-18-24-clu513
Figure 3. Immunofluorescent detection of IRAC I and IRAC II. HeLa cells 
were transfected with pcDNA4/TO (panels a and b), pcDNA4/TO-IRAC-I 
(panels c and d), and pcDNA4/TO-IRAC-II (panels e and f) vectors. 
Thirty-six hours after transfection, the cells were treated for indirect 
immunofluorescent staining: mouse serum anti-IRAC I (part A, panels a, c 
and e), mouse serum anti-IRAC II (part A, panels b, d and f), mAb I1a raised 
against IRAC I (part B, panels a, c and e) and mAb I2a raised against IRAC 
II (part B, panels b, d and f) were used as first antibodies and were revealed 
by Alexa 488-GAM. The side of each panel in parts A and B corresponds to 
125 and 250 µm of the specimen, respectively.
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(Ribeiro 
 
et al
 
., 2006). Among these, clones 113 and 120
differed in length but otherwise had identical sequences,
and so were combined as a single sequence.
We investigated the evolution of these genes by phyloge-
netic analyses of their aligned protein sequences. Owing to
the truncated nature of the Salp9 sequence (Fig. 1) analysis
of all 12 sequences was restricted to 66 aligned residues
(Fig. 6A), whereas analysis of 11 sequences (excluding
Salp9) included 156 sites (Fig. 6B). The sequences fall into
three clades: one including one sequence from each of the
three species (IRAC II, ISAC-1 and Salp9), one including
eight sequences from 
 
I. scapularis
 
, and one comprised
of 
 
I. ricinus
 
 IRAC I only. The only topological differences
between the two trees concern the position of clone 122
relative to the other 
 
I. scapularis
 
 sequences: over the 3
 
′
 
region of the gene clone 122 is most closely related to Isac
(Fig. 6A), whereas when the whole sequence is considered
clone 122 does not seem specifically closely related to any
of the other 
 
I. scapularis
 
 sequences (Fig. 6B). This appears
to reflect recombination events during the divergence of
these sequences.
While the phylogenetic analyses yield unrooted trees,
the simplest interpretation would seem to be to place the
root between the IRAC II clade and the other sequences
(as in Fig. 6); then the root of the tree reflects a gene dupli-
cation in an ancestral species. To one side of the root, IRAC II,
ISAC-1 and Salp9 seem to represent orthologous genes
in 
 
I. ricinus
 
, 
 
I. pacificus
 
 and 
 
I. scapularis
 
, respectively. To the
other side of the root, there appear to have been multiple
gene duplication events within the 
 
I. scapularis
 
 lineage.
IRAC I could be the orthologue of this 
 
I. scapularis
 
 gene
family, although this would imply a much faster rate of diver-
gence among the IRAC I-like sequences than among the
IRAC II-like sequences.
The interpretation of IRAC II, ISAC-1 and Salp9 as being
orthologous does not seem consistent with an earlier phylo-
genetic analysis based on a short segment of the mitochon-
drial 16S rRNA sequence, which placed 
 
I. ricinus
 
 as an
outgroup to 
 
I. scapularis
 
 and 
 
I. pacificus
 
 (Black & Piesman,
1994). While our phylogeny (Fig. 6A) was derived from pro-
tein sequences, the greater similarity between 
 
I. ricinus and
I. pacificus is also seen at the nucleotide level, in terms of
Figure 4. Expression of IRAC I and IRAC II 
proteins in Ixodes ricinus salivary glands. 
Parafrontal cryo-sections were performed in 
unfed (panels a, c and e) or 4 days engorged 
(panels b, d and f) adult female I. ricinus ticks. 
Sections were treated for indirect 
immunofluorescent staining: mAb 198 (isotypic 
control), mAb I1a raised against IRAC I (panels c 
and d) and mAb I2a raised against IRAC II 
(panels e and f) were used as first antibodies 
and were revealed by Alexa 488-GAM. Cell nuclei 
were stained with TO-PRO-3 iodide. Sections 
were examined by confocal microscopy for 
green (Alexa-GAM) and red (TO-PRO-3 iodide) 
fluorescent signals. Pictures represent the 
merged image of the red and green emissions. 
The side of each panel corresponds to 1000 µm 
of the specimen.
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KS, the extent of divergence at silent sites (Table 2). The
sequences of two other protein-coding nuclear genes,
encoding calreticulin and a metalloprotease, are available from
all three species: in both cases, the smallest interspecies
difference is between I. ricinus and I. pacificus (Table 2), as
for IRAC II and ISAC-1. Thus, the nuclear gene sequences
consistently indicate a relationship among these three species
different from that obtained from mitochondrial sequences.
The extent of synonymous nucleotide substitution
among IRAC II, ISAC-1 and Salp9 is consistent with these
genes being orthologues (Table 2). For example, excluding
the anticomplement protein genes, KS values for genes
available for comparison between I. ricinus and I. scapularis
range from 0.035 to 0.138. This variation probably reflects
constraints on silent sites due to selection on codon usage,
to maximize the efficiency and/or accuracy of translation.
Such selection on codon usage has been reported for
another arthropod, Drosophila, where highly expressed
genes have strongly biased, G + C-rich, codon usage
(Shields et al., 1988; Duret & Mouchiroud, 1999). In the
comparison between I. ricinus and I. scapularis, the four
genes with the most G + C-rich codon usage have the
smallest values of KS, consistent with selective constraint;
in contrast, IRAC II/Salp9 and the metalloprotease gene both
have relatively unbiased codon usage, and similar (higher)
KS values. Conversely, the KS values for comparisons between
IRAC I and I. scapularis homologues are much higher
Table 2. Extent of divergence among Ixodes species. Divergence for 
protein-coding sequences was estimated as the numbers of synonymous 
(KS) and nonsynonymous (KA) substitutions per site, by Li’s method (Li, 
1993), applied to L codons compared. The average G + C content at 
synonymously variable third positions of codons (GC3s) is also shown. For 
IRAC II vs. ISAC-1, a second comparison is made (*) restricted to the region 
available for Salp9
Gene KS KA KA/KS L GC3s
I. ricinus vs. I. scapularis
IRAC I/Isac 0.277 0.244 0.88 184 0.42
IRAC I/Salp20 0.241 0.224 0.93 183 0.44
IRAC I/ISNU-L-ISN-50 0.276 0.228 0.83 174 0.44
IRAC I/ISNU-cluster-52 0.304 0.221 0.73 173 0.43
IRAC II/Salp9 0.156 0.182 1.17 79 0.51
Calreticulin 0.097 0.006 0.07 413 0.88
Ferritin 0.095 0.008 0.08 172 0.92
Metalloprotease 0.138 0.062 0.45 339 0.50
RP S18 0.050 0.004 0.07 146 0.79
Actin 0.035 0.004 0.11 136 0.89
I. ricinus vs. I. pacificus
IRAC II/ISAC-1 0.047 0.110 2.33 178 0.48
IRAC II/ISAC-1* 0.037 0.134 3.58 81 0.49
Calreticulin 0.053 0.006 0.11 413 0.88
Metalloprotease 0.106 0.052 0.49 339 0.49
I. scapularis vs. I. pacificus
Salp9/ISAC-1 0.130 0.200 1.54 79 0.50
Calreticulin 0.067 0.006 0.09 413 0.88
Metalloprotease 0.131 0.055 0.42 340 0.50
Figure 5. Expression of IRAC I and IRAC II proteins in different Ixodes 
ricinus ticks. Twelve adult engorged female ticks were collected on game 
animals killed in various forests throughout Belgium. Micro-dissected left 
and right salivary glands were incubated with mAb I1a raised against IRAC 
I (panels c, e and g) and mAb I2a raised against IRAC II (panels d, f and h), 
respectively. Panels a and b represent salivary glands incubated with mAb 
198 used as an isotypic control. Primary antibodies were revealed by Alexa 
488-GAM. The side of each panel corresponds to 500 µm of the specimen. 
Representative results obtained from three ticks are presented in the figure; 
similar results were obtained with all ticks tested.
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(Table 2), suggesting that they may have been diverging
since before the speciation of I. ricinus and I. scapularis.
Adaptive evolution of IRAC genes
The ratio of nonsynonymous vs. synonymous substitutions
(KA/KS) can be used to make inferences about the pattern
of evolution in genes (Sharp, 1997). This ratio is normally
much lower than 1, reflecting the constraint on nonsynonym-
ous substitutions, and the relative lack of constraint on
synonymous substitutions; for example, among a large
sample of genes compared between mouse and rat, the
median value was 0.08 (Sharp, 1997). Values similar to this
are seen for the calreticulin, actin, ferritin and RP S18
genes, despite their apparently constrained KS values,
while that for the metalloprotease gene is somewhat higher
(Table 2). In contrast, in the comparisons of IRAC II, ISAC-1
and Salp9 the KA/KS values are greater than 1. Values of
the KA/KS ratio can increase either by a relaxation of
selective constraint on the protein sequence or by positive
selection for amino acid changes, but only the latter force
can elevate the values above 1. Furthermore, it is difficult
for the ratio to be greater than 1, even with positive selection
for amino acid changes, unless there is selection of a large
number of changes over a short period of time (Sharp,
1997). Thus, the high values of KA/KS seen for IRAC II,
ISAC-1 and Salp9 are strong evidence that these sequences
have been subject to positive diversifying selection for
amino acid changes during their evolution. The values for
IRAC I compared with the most closely related I. scapularis
homologues were also unusually high (Table 2); although
these values were a little under 1, they are more likely to
reflect positive diversifying selection than a near complete
absence of selective constraint.
Discussion
Several distinct arthropod groups have independently
evolved haematophagous behaviour. The ancestors of
Ixodes ticks were scavengers (Mans & Neitz, 2004). To
develop their haematophagous behaviour characterized by
a long continuous blood meal, Ixodes ticks had to acquire
mechanisms to counteract several host physiological
processes. Several observations listed in the introduction
indicate that the alternative pathway of the host immune
system has exerted a strong selective pressure on these
parasites during their evolution. Reinforcing this inter-
pretation, the present study suggests that ticks belonging
to the I. ricinus complex have a gene family encoding
multiple anticomplement proteins, evolving under positive
diversifying selection.
The Ixodes family of anticomplement proteins does not
appear to have detectable homology with any previously
reported sequences. In particular, IRAC homologues do
not contain any amino acid motifs found within the SCR of
RCA (McLure et al., 2004). However, like SCRs, all IRAC
homologues (except the apparently incomplete Salp9
sequence) contain four conserved cysteines essential for
the anticomplement activity of RCA. These data suggest
that the anticomplement activity of the proteins reported
here has been acquired through a process of convergent
evolution. Ixodes ticks are hard ticks that differ from related
soft ticks in several morphological features as well as their
feeding behaviour. However, soft ticks have apparently
developed their haematophagous behaviour independently
of hard ticks (Mans & Neitz, 2004), and so it would be inter-
esting to characterize the anticomplement activity of soft
tick saliva, to identify the genes responsible for this activity
and study their phylogenetic relationship, if any, with the
IRAC homologues. The identification of additional novel
salivary anticomplement molecules acquired through con-
vergent evolution by blood feeding arthropods would pro-
vide further support for the importance of complement
inhibition in the host–parasite relationship. Interestingly, a
recent study described the identification of a complement
inhibitor of C5 activation from the soft tick Ornithodoros
moubata (Nunn et al., 2005); this molecule, termed OmCI,
is the first lipocalin family member shown to inhibit com-
plement activation.
Figure 6. Phylogenetic relationships among the protein sequences of IRAC 
homologues. (A) Twelve sequences compared across 66 aligned residues. 
(B) Eleven sequences (Salp9 excluded) compared across 156 aligned 
residues. Horizontal branch lengths are drawn to scale, with the scale bars 
representing 0.05 (A) and 0.02 (B) replacements per site. Numbers on 
internal branches indicate estimated posterior probabilities.
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The data presented in this study revealed that both IRAC I
and II exhibit anticomplement properties similar to those
described for Isac (Fig. 2). Analysis of the expression of
IRAC I and IRAC II in different ticks (Fig. 5), as well as
consideration of the extent of divergence between the
IRAC I and II sequences, indicate that they are paralogues
generated by gene duplication, rather than allelic variants. In
phylogenetic analyses Isac is more closely related to IRAC I
than IRAC II, but again the extent of divergence between
IRAC I and Isac is so great, even at silent sites, as to suggest
that Isac and IRAC I are also paralogues (Fig. 6, Table 2).
The selective advantage conferred by expressing these
paralogous proteins could be explained by a synergistic
effect resulting from their coexpression. Alternatively, the
different paralogous proteins may have different inhibitory
activities against the complement of different host species;
it will be interesting to investigate whether the combination
of IRAC I and IRAC II has increased the host range of I. ricinus
ticks. The anticomplement activity of the other homologous
sequences has not been tested so far. As described above,
it is possible that diversifying selection has led to these
sequences acquiring altered biological properties.
Two types of vaccines are possible against ectoparasites
such as ticks, using antigens either ‘concealed’ or ‘exposed’
to the immune system during natural infestation. A vaccine
using ‘concealed’ antigens is already commercially available
(TickGARD™ in West Ride, Australia and Gavac™ in
Havana, Cuba). These vaccines relied on the Bm86 antigen,
a midgut membrane-bound protein of the Boophilus micro-
plus tick (Willadsen et al., 1989). This vaccination induces an
antibody-dependent immunity that causes destruction of
the midgut and leaking of the ingested blood into the body
cavity of the tick inducing death or reducing fertility (Rand
et al., 1989). Notwithstanding the ingenious aspect of ‘con-
cealed’ antigen-based vaccines, they exhibit several dis-
advantages. First, they confer only short-term protective
immunity because natural infestation does not boost the
immune system. Consequently, these vaccines require
frequent boosters. Second, the immune response induced
by ‘concealed’ antigen based vaccines does not induce an
early rejection of the tick and consequently is unable to
prevent the transmission of the pathogens carried by the
parasite. ‘Exposed’ antigen-based vaccines should avoid
these disadvantages.
Two main arguments suggest that IRAC proteins are
good ‘exposed’ candidate antigens for the development of
an antitick vaccine, which could interrupt the tick blood meal
shortly after the bite, and consequently reduce the risk of
transmission of tick-borne pathogens. First, cases of host
resistance to ticks have been described in which the com-
plement system is implicated with a predominant part of the
alternative pathway (Wikel, 1979; Ribeiro, 1987; Lawrie
et al., 1999); consequently, it is crucial to block tick proteins
able to inhibit this part of the immune system. Second, IRAC
I and IRAC II were proved to be expressed constitutively
in the saliva of unfed ticks (Fig. 4) suggesting their import-
ance in the earlier steps of the blood meal. This constitutive
expression ensures that IRAC molecules will be among the
first antigens injected into the host skin. Inducing an appro-
priate humoral immune response could have several
advantages for the host. Neutralization of IRAC molecules
by antibodies should allow the default activation of the
alternative pathway. Moreover, the immune complexes
generated by the binding of the host antibodies on IRAC
molecules should activate the classical pathway. All together,
the activation of these two pathways should generate an
inflammation that could induce the interruption of the blood
meal. It is also important to note that the anticomplement
activity mediated by IRAC homologues represents a mech-
anism of protection against the host complement for the
pathogens transmitted by the tick saliva. Inhibition of IRAC
homologues should preserve the alternative pathway of the
host at the site of the bite and therefore maintain the ability
of the host immune system to control the infection at a very
early stage. Despite the homology existing between IRAC
proteins, the results presented in Fig. 3 (panel B) suggest
that a vaccine based on these molecules should contain
epitopes from both paralogues, or even epitopes from each
member of the anticomplement protein family. Experiments
to test the potential of IRAC molecules as antigens for the
development of an antitick vaccine are in progress.
In conclusion, the present study demonstrates that ticks
belonging to the Ixodes ricinus complex encode a family of
anticomplement proteins that represent a group of candi-
date antigens for the development of an antitick vaccine
potentially able to induce an early rejection of the tick and/
or inhibition of transmission of tick-borne diseases.
Experimental procedures
Purification of mRNA from 5-day-fed tick salivary glands
Salivary glands of 50 adult female I. ricinus ticks from a laboratory
colony engorged for 5 days on the ears of New Zealand White
rabbits were dissected and immediately frozen in liquid nitrogen.
To extract mRNA, salivary glands were crushed in liquid nitrogen
using a mortar and a pestle. Purification of approximately 400 ng of
mRNA was then performed using the Fast Track 2.0 kit (Invitrogen,
Merelbeke, Belgium).
Isolation of cDNA encoding IRACs by reverse 
transcriptase–polymerase chain reaction
RT reactions were performed on 150 ng of I. ricinus salivary gland
mRNA using First-Strand cDNA Synthesis Kit (Amersham Phar-
macia Biotech, Piscataway, NJ). The 5′-NotI-d(T)18-3′ primer provided
in the kit was used for these reactions. Finally, cDNA products were
amplified by PCR using the forward primer 5′-ACAGCACTGAG-
GTTTCAGA G-3′ and the reverse primer 5′-NotI-d(T)18-3′. The former
primer was designed based on Isac cDNA sequence (nucleotides
−36 to −17 according to the translation initiation site, GenBank
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accession number AF270496). RT–PCR products were TA-cloned
into the pGEM-T easy vector (Promega, Madison, WI) and sequenced.
Nucleotide sequence accession numbers
The sequences reported in this paper have been deposited in the
GenBank database: IRAC I cDNA (AY878714) and IRAC II cDNA
(AY878715). The following previously published sequences were
also used in this study: Isac (AF270496), Salp9 (AF278574),
Salp20 (AF209917), clone 113 (AY956386), clone 120 (AY956387),
clone 122 (AY956388), isolate ISNU-L-ISN-50 (DQ066167), isolate
ISNU-L-ISNU-51 (DQ066183), isolate ISNU-cluster-52
(DQ066136), isolate IS-18-24-clu513 (DQ065897), ISAC-1
(AY674272), I. ricinus ferritin (AF068224), I. scapularis ferritin
(AY277906), I. ricinus metalloprotease (MP) (AJ269650), I. scapularis
MP (AY264367), I. pacificus MP (AY674268), I. ricinus ribosomal
protein S18 (RP S18) (AY342352), I. scapularis RP S18
(CA763772), I. ricinus calreticulin (AY395272), I. scapularis calre-
ticulin (AY395273), I. pacificus calreticulin (AY395269), I. ricinus
actin (AJ889837) and I. scapularis actin (AF426178).
Construction of mammalian expression vectors encoding IRACs
IRAC I and IRAC II cDNAs obtained by the RT–PCR approach
described above were used as templates to amplify IRAC I and II
ORFs. Amplifications of IRAC I were performed with the sense
primer 5′-CCGGATCCATGAAGACTGCGCTGAC-3′ containing a
5′ BamHI site and nucleotides 1–17 (nucleotides 1–3 encode the
initiation methionine) and either the reverse primer 5′-CCCTC-
GAGTCATGGGATGGCCTCAGGTT-3′ corresponding to the ORF
3′ end (nucleotides 535–555), the stop codon, and a XhoI site or
the reverse primer 5′-CCCTCGAGTGGGATGGCCTCAGGTTGA
G-3′ corresponding to the 3′ end of the ORF (nucleotides 533–
552) and a XhoI site. Similarly, amplifications of IRAC II were
performed with the sense primer 5′-CCGGATCCATGAGGACT-
GCGC TGAC-3′ containing a 5′ BamHI site and nucleotides 1–17
and either the reverse primer 5′-GGCTCGAGTCAGGCGAT-
GGCTCTAA-3′ corresponding to the ORF 3′ end (nucleotides
520–537), the stop codon, and a XhoI site, or the reverse primer
5′-GGCTCGAGGGCGATGGCTCTAAGTT-3′ corresponding to
the 3′ end of the ORF (nucleotides 517–534) and a XhoI site. The
four PCR products were subcloned into pGEM-T easy (Promega),
resulting in pGEM-T-IRAC (I or II) with or without stop codon.
Inserts were controlled by sequencing. Fragments encoding IRAC
I or II were excised from pGEM-T-IRAC (I or II) by BamHI/XhoI
digestion and ligated into pcDNA4/TO His/Myc vector (Invitrogen)
digested by the same endonucleases, resulting in pcDNA4/
TO-IRAC I or II His-tagged and pcDNA4/TO-IRAC I or II wild type.
Expression of IRACs in HeLa cells
HeLa cells (ATCC, CCL-2) were grown in RPMI 1640 medium
(Gibco, Merelbeke, Belgium) supplemented with 2% (v/v) penicillin-
streptomycin (Gibco) and 10% (v/v) heat-inactivated fetal calf
serum (Biowhittaker, East Rutherford, NJ). Subconfluent HeLa cells
were transfected using the Effectene reagent (Qiagen, Venlo, The
Netherlands). The following vectors were transfected: pcDNA4/
TO-IRAC I or II His-tagged, pcDNA4/TO-IRAC I or II wild type and
the pcDNA4/TO empty vector (negative control). Seventeen hours
after transfection, cell supernatant was replaced with serum-free
culture medium. After an additional incubation period of 24 h, the
culture medium was collected, clarified by centrifugation at 200 g
for 10 min and concentrated 20-fold using Centricon Plus-20
(10 kDa cut-off) (Millipore Corp., Billerica, MA). Concentrated
supernatants were stored at −80 °C until use.
Antibodies
Mouse antisera, hereafter called anti-IRAC I and anti-IRAC II were
raised against IRAC I and IRAC II His-tagged molecules expressed
in HeLa cells as described above. In addition, two mouse mAb
specific of IRAC I (mAb I1a) or IRAC II (mAb I2a) were also pro-
duced. mAb I1a and mAb I2a are both IgG1. mAb 198 (Serotec,
Oxford, UK) raised against rabbit CD11b is an IgG1 and was used
as isotypic control for mAb I1a and mAb I2a. Rabbit sera raised
against human C3 (anti-C3) (Serotec) and factor B (fB) (anti-fB)
(DakoCytomation, Glostrup, Denmark) were also used in this study.
Anticomplement assays
The ability of IRAC I and IRAC II to inhibit the alternative pathway
of the complement system was tested using the AH50 assay as
described elsewhere (Coligan et al., 1992). This assay relies on
the lysis of unsensitized rabbit erythrocytes (Erab) by human serum
in a buffer containing the calcium chelator EGTA, thus preventing
the activation of the calcium-dependent classical pathway. Briefly,
50 µl of Erab (2 × 108 cells per ml in ice-cold gelatin/veronal-
buffered saline with MgCl2 and EGTA (GVB/Mg EGTA)) were
added on ice to 12.5 µl of human serum and increasing amounts
of the concentrated cell supernatant to be tested. The final volume
of each sample was then brought to 150 µl with GVB/Mg EGTA
buffer. For background and total lysis samples, 100 µl of GVB/Mg
EGTA buffer or 100 µl of water were added to the 50 µl of Erab,
respectively. After an incubation period of 60 min at 37 °C, 1.2 ml
of ice cold 0.15 M NaCl was added to each sample to stop haemo-
lysis. After centrifugation at 1250 g for 10 min at 4 °C, the super-
natant was collected and its optical density measured at 412 nm
(OD412). Relative haemolysis of each sample was calculated as
follow: (test sample OD412 − background sample OD412)/(total
lysis sample OD412 − background sample OD412). The ability of
IRAC I and IRAC II to inhibit the classical pathway of the comple-
ment system was tested using the CH50 assay as described in
detail elsewhere (Coligan et al., 1992).
Immunoblotting
Concentrated cell supernatants were analysed by immunoblotting
as described previously (Gillet et al., 2005). Anti-IRAC I (diluted
1 : 1000) and anti-IRAC II (diluted 1 : 5000) were used as primary
antibodies. Peroxidase-conjugated rabbit immunoglobulin anti-
mouse immunoglobulins (diluted 1 : 10 000, Dako) were used as
secondary antibody.
Enzyme-linked immunosorbent assays for measuring C3 and 
fB deposition
The ability of the IRAC I and II molecules to act on C3 and fB during
alternative pathway activation was tested using an ELISA assay as
described elsewhere with minor modifications (Valenzuela et al.,
2000). Briefly, 96 well plates were coated with 50 µl of 0.1% (w/v)
agarose in water. To test the ability of IRACs to prevent C3 or fB
binding to the plate, 0.5 µl of concentrated cell supernatant
containing IRACs was incubated in a 50 µl final volume of 20 mM
HEPES, pH 7.4, 150 mM NaCl, 5 mM EGTA, 2 mM MgCl2 (HEM)
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containing 10% human serum for 30 min at 37 °C. For blank
control, MgCl2 and EGTA were substituted by 10 mM EDTA, thus
inhibiting complement activation. After five washes with 200 µl of
HEM supplemented with 10 mg/ml of bovine serum albumin
(HEMB), C3b and fB bound plates were revealed by ELISA.
Anti-C3b (diluted 1/2500) and anti-fB sera (diluted 1/250) used as
primary antibodies were incubated for 1 h at 37 °C in HEMB. After
extensive washing with HEMB, samples were incubated for 1 h at
37 °C with peroxidase-conjugated IgG goat antirabbit immunoglo-
bulins (diluted 1 : 200) (Dako Cytomation), as secondary antibody.
Quantification of peroxidase activity was then performed as
described elsewhere (Valenzuela et al., 2000). To test the ability of
IRACs to uncouple previously bound C3 and fB, 50 µl of HEM con-
taining 10% human serum was incubated for 75 min at 37 °C to
allow C3b and fB binding to plate. After three washes with HEM,
increasing volumes of concentrated supernatant containing IRACs
were incubated in a 50 µl final volume of HEM containing 10% heat
inactivated human serum for 30 min at 37 °C. After five washes
with 200 µl of HEMB, samples were treated as described above for
relative quantification of C3b and fB by ELISA.
Indirect immunofluorescent staining
Indirect immunofluorescent stainings were performed on three
types of samples: cryosections of ticks, microdissected tick salivary
glands and cell monolayers grown on glass coverslips. Unfed or
4-day-fed ticks were embedded in tissue-tek compound (Sakura,
Zouterwoude, The Netherlands) and frozen in liquid nitrogen.
Twenty micron thick parafrontal sections were then performed
through the entire tick and bound to poly L-lysin-coated slides. All
types of samples were fixed in phosphate-buffered saline (PBS)
(PBS: 3 mM KCl, 1.5 mM KH2PO4, 0.14 M NaCl, 6.5 mM Na2HPO4,
pH 7.2) containing 4% (w/v) paraformaldehyde (Merck, White-
house Station, NJ) for 15 min on ice and then 30 min at room
temperature. After washing with PBS, the samples were then per-
meabilized in PBS containing 0.1% (w/v) NP40 (Fluka, St. Louis,
MO) for 20 min at 37 °C. Immunofluorescent stainings (incubation
and washes) were performed in PBS containing 10% (v/v) fetal calf
serum (PBSF). The samples were incubated at 37 °C for 45 min
with anti-IRAC I or II sera (diluted 1/50), preimmune mouse sera
(diluted 1/50, negative control), mAb I1a (diluted 1/100), mAb I2a
(diluted 1/500) and mAb 198 (diluted 1/100), as primary anti-
bodies. After three washes, the samples were incubated at 37 °C
for 30 min with Alexa488-conjugated F(ab′)2 goat antimouse IgG
(Alexa-GAM) 10 µg/ml (Molecular Probes, Merelbeke, Belgium)
as secondary conjugate. After three washes with PBSF and a final
wash with PBS, samples were mounted as described elsewhere
(Vanderplasschen et al., 2000). For tick cryosections, cell nuclei were
counter-stained just before mounting by incubation in PBS contain-
ing 0.1% (w/v) TO-PRO-3 iodide (Molecular Probes) for 10 min.
Confocal microscopy analysis
Confocal microscopy analyses were performed with a TCS SP
confocal microscope (Leica) as described previously (Vander-
plasschen et al., 2000).
Statistical analysis
Statistical comparisons were assessed by a two-way analysis of
variance (ANOVA II). When F ratios were significant (P < 0.05), the
method of Scheffe’s post hoc tests was used.
Sequence analysis
Sequences were aligned using CLUSTALW (Thompson et al.,
1994), with subsequent minor manual adjustment; sites with a gap
in any sequence were then excluded. Phylogenetic trees were
inferred by the Bayesian method (Huelsenbeck & Ronquist, 2001)
implemented in the parallel version of MrBayes v3.1.2 (Ronquist &
Huelsenbeck, 2003; Altekar et al., 2004), using the Jones, Taylor
and Thornton (Jones et al., 1992) model of amino acid replacements
with a gamma distribution of rates among sites (Yang, 1993). The
analysis was run for 1 million generations, with a burn-in of 25%;
estimated sample sizes from the Tracer program (http://evolve.
zoo.ox.ac.uk/software.html/id=tracer) were greater than 2785.
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